TP53 and cancer: For instance, mutations in specific cancer genes as TP53 and ARID1A show a tendency to be clonal, but focusing on subclonal mutations in known cancer driver genes, in APOBEC-associated BLCA more than 45% of subclonal mutations in driver genes occurred in an APOBEC context [172].